Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1997-03-06
1999-02-02
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
514 11, 514937, 514938, A61K 9127, A61K 9107, A61K 3813
Patent
active
058661590
ABSTRACT:
Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight mono- or poly-oxy-alkane diol, e.g. Transcutol or Glycofurol, as hydrophilic component. Compositions are also provided comprising a cyclosporin and (1.1) and, suitably, also a saccharide monoester, e.g. raffinose or saccharose monolaurate. Dosage forms include topical formulations and, in particular, oral dosage forms.
REFERENCES:
patent: 3288824 (1966-11-01), Mahler et al.
patent: 3811345 (1974-05-01), Urton
patent: 3954967 (1976-05-01), Urton
patent: 4073943 (1978-02-01), Wretlind et al.
patent: 4146499 (1979-03-01), Rosano
patent: 4156719 (1979-05-01), Sezaki et al.
patent: 4388307 (1983-06-01), Cavanak
patent: 4567161 (1986-01-01), Posanski et al.
patent: 4695450 (1987-09-01), Bauer et al.
patent: 4719239 (1988-01-01), Muller et al.
patent: 4794000 (1988-12-01), Ecanow
patent: 4797272 (1989-01-01), Linn et al.
patent: 4797273 (1989-01-01), Linn et al.
patent: 4798823 (1989-01-01), Witzel
patent: 4835002 (1989-05-01), Wolf et al.
patent: 4888239 (1989-12-01), Brox
patent: 4914188 (1990-04-01), Dumont et al.
patent: 4963367 (1990-10-01), Ecanow
patent: 4990337 (1991-02-01), Kurihara et al.
patent: 4996193 (1991-02-01), Hewitt et al.
patent: 5037653 (1991-08-01), Dawson
patent: 5047396 (1991-09-01), Orban et al.
patent: 5154754 (1992-10-01), Damo et al.
95: 225610k, Anon. (1981).
Mizushima, 86-335072/51 (Jul. 26, 1985).
Takada, 87-024776/04 (Apr. 4, 1985).
Anon., Research Disclosure 21143 (Nov. 1981).
Beyer, et al., Phamazie in unserer Zeit, vol. 12(2): 55-60 (1983) (translation).
Bhargava, et al., Pharmaceutical Technology, Mar. 1987.
Cavanak and Sucker, Prog. Allergy vol. 38:65-72 (1986).
Ekman, S., Lipids 22: 657-663 (1987).
Jayakrishnan, et al., J. Soc. Cosmet. Chem. 34: 335-350 (1983).
Muller, et al., Pharm. Ind. 50(3): 370-375 (1988) (translation).
Muller, et al., Pharm. Ind. 50(11): 1301-1306 (1988) (translation).
Remington's Pharmaceutical Sciences (17th ed.), Microemulsions, Chapter 20, pp. 298-299 (1985).
Reymond, et al., Pharmaceutical Research vol. 1 5(10): 673-767 (1988).
Reymond, et al., Pharmaceutical Research vol. 5(10): 677-679 (1988).
Ritschel, et al., Pharmaceutical Research vol. 5(10): Suppl. 108 (1988).
Ritchel, et al., Meth and Find Exp Clin Pharmacol. vol. 11(4): 281-87 (1989).
Stupar, et al., Goldschmidt Inforwist Essein, vol. 52: 22-28 (1982) (translation).
Takada, et al., J. Pharmacobio-Dyn. vol. 8: 320-323 (1985).
Takada, et al., J. Pharmacobio-Dyn. vol. 9: 156-160 (1986).
Takada, et al., J. Pharmaceutical Research vol. 3(1): 48-51 (1986).
Takada, et al., J. Pharmacobio-Dyn. vol. 11: 80-87 (1988).
Takada, et al., Int. of Pharmaceutics, vol. 44: 107-116 (1988).
Tarr, et al., Pharmaceutical Research, vol. 6(1): 40-43 (1989).
Yanagawa, et al., J. Microencapsulation 6(2): 161-164 (1989).
Ziegenmeyer, et al., Acta Pharmaceutica Technologica, vol. 26(4): 273-275 (1980) (translation).
Hahn, Biodegradable Tensides (1988) (translation).
Mubarak, Development and Testing of New Microemulsions (1982) (translation).
Pohler, Micro-Emulsion Gels Structural Investigations and Galenical Properties (1983) (translation).
Reymond, In Vitro In Vivo Model for the Absorption of Cyclosporin A (1986) (translation).
Hauer Birgit
Meinzer Armin
Posanski Ulrich
Richter Friedrich
Kishore Gollamudi S.
Mathias Marla J.
Novartis AG
LandOfFree
Pharmaceutical compositions comprising cyclosporins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising cyclosporins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising cyclosporins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114795